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Choline dehydrogenase interacts with SQSTM1/p62 to 





Choline dehydrogenase interacts with SQSTM1/p62 to recruit LC3 
and stimulate mitophagy 
    CHDH (choline dehydrogenase) is an enzyme catalyzing the dehydrogenation of 
choline to betaine aldehyde in mitochondria. Apart from this well-known activity, I 
report here a pivotal role of CHDH in mitophagy. Knockdown of CHDH expression 
impairs CCCP-induced mitophagy and PARK2/parkin-mediated clearance of 
mitochondria in mammalian cells, including HeLa cells and SN4741 dopaminergic 
neuronal cells. Conversely, overexpression of CHDH accelerates PARK2-mediated 
mitophagy. CHDH is found on both the outer and inner membranes of mitochondria 
in resting cells. Interestingly, upon induction of mitophagy, CHDH accumulates on the 
outer membrane in a mitochondrial potential-dependent manner. I found that CHDH is 
not a substrate of PARK2 but interacts with SQSTM1 independently of PARK2 to 
recruit SQSTM1 into depolarized mitochondria. The FB1 domain of CHDH is 
 
ii 
exposed to the cytosol and is required for the interaction with SQSTM1, and 
overexpression of the FB1 domain only in cytosol reduces CCCP-induced 
mitochondrial degradation via competitive interaction with SQSTM1. In addition, 
CHDH, but not the CHDH FB1 deletion mutant, forms a ternary protein complex with 
SQSTM1 and MAP1LC3 (LC3), leading to loading of LC3 onto the damaged 
mitochondria via SQSTM1. Further, CHDH is crucial to the mitophagy induced by 
MPP+ in SN4741 cells. Overall, my results suggest that CHDH is required for 
PARK2-mediated mitophagy for the recruitment of SQSTM1 and LC3 onto the 
mitochondria for cargo recognition. 
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CHDH is an enzyme catalyzing the dehydrogenation of choline to betaine 
aldehyde in the mitochondria.1 Betaine aldehyde is subsequently converted to betaine, 
an important methyl donor for the synthesis of methionine from homocysteine.2, 3 
CHDH has been highlighted by Ma et al., who report that CHDH is overexpressed in 
patients with a favorable outcome associated with tamoxifen monotherapy in a cohort 
of early-stage estrogen receptor-positive breast cancer patients.4 In addition, a 
population-based study shows that CHDH expression correlates with ESR (estrogen 
receptor) and HER2 status and is regulated by estrogen in an ESR-dependent manner.5 
A recent study demonstrates that CHDH plays a pivotal role in mitochondrial function 
in several tissues, with the most striking effects in sperm of chdh-/- mice.6 Several 
single nucleotide polymorphisms (SNPs) of CHDH are common in humans. Between 
42 to 47% of the population carrying one allele of the rs12676 SNP shows liver and 
muscle dysfunction when fed a choline-deficient diet.7, 8 Moreover, this SNP affects 
 
２ 
the motility and mitochondrial morphology of human sperm.9 
Mitochondrial quality control is performed within certain steps along with the 
level of damage.10 Cells must eliminate mitochondria when they fail to repair their 
components using proteolytic systems or ROS regulation. Autophagic machineries are 
employed in this type of organellar-level mitochondrial degradation, termed 
‘mitophagy,’ which is critical for the maintenance of cellular homeostasis and 
survival.11 Autophagy is responsible for the initial flux of mitophagy, and the two 
processes share the same pathway, including ULK1, ATG13,12, 13 MAP1LC3B/LC3B 
(refer to LC3 hereafter), and BECN1/Beclin114 with a controversy in case of 
BECN1.15 Inhibition of MTORC1 is also required for autophagy and mitophagy.16 
However, it remains unclear which critical factor targets autophagic machineries to the 
mitochondria. In recent years, PINK1/PARK6 (PTEN induced putative kinase 1) and 
PARK2/parkin (parkin RBR E3 ubiquitin protein ligase) have emerged as a pivotal 
paradigm of mitophagic process. These genes are mutated in autosomal recessive 
Parkinson disease (PD)17, 18 and contribute to regulation of mitochondrial integrity, 
 
３ 
including mitophagy.14 PINK1 has a short half-life and is rapidly degraded under 
steady-state conditions by proteases located in the inner membrane (IM) of 
mitochondria. However, once the mitochondrial membrane potential has dissipated, it 
becomes stable and recruits PARK2.19, 20 The ubiquitin-ligase activity of PARK2 is 
then activated21 and promotes ubiquitination of mitochondrial proteins, driving 
mitophagy. Although the mechanism of mitophagy has been intensively studied,22-24 
the mitophagy-specific factors remain unclear. 
In this study, I assess the role of CHDH in PARK2-mediated mitophagy. Beyond 
its well-known role in betaine production, I demonstrate that CHDH is required for 
mitophagy in which CHDH interacts with SQSTM1, a mitophagic adaptor molecule, 




2. MATERIALS AND METHODS 
 
2.1. Cell culture and transfection 
    HeLa, HEK293T and SH-SY5Y cells were grown in DMEM (Hyclone, 
SH30243.01) supplemented with 10% fetal bovine serum (Hyclone, SH30919.03), 50 
U/mL penicillin and 50 µg/mL streptomycin at 37 °C under 5% CO2. SN4741 
dopaminergic neuronal cells were cultured as described previously.28 Stable cell lines 
were generated after selection with G418 (1 mg/mL; Invitrogen, 10131027) for 2 
weeks following DNA transfection and confirmed by western blot analysis. sqstm1 
MEFs were gifted by Dr. J. Shin (Sungkyunkwan University, Korea). DNA, shRNA 
and siRNA transfections were performed with Polyfect reagent (Qiagen, 1015586) 
and Lipofectamine 2000 reagent (Invitrogen, 11668019) for 24 and 48 h, respectively, 
according to the manufacturer’s instructions. 
 
2.2. Plasmids and siRNA 
 
５ 
    CHDH shRNA constructs were generated in pSUPER-neo (OligoEngine, VEC-
PBS-0004) using the following target sequence for human CHDH: 5 -́CCA CAT TCA 
GTC AGA TAA A-3  ́and for mouse Chdh: 5 -́GGT AAT GAT TGC AGA GAA A-3 .́ 
Serial deletion (∆) mutants of CHDH were generated by excising the FB1 domain 
(115 to 978) (CHDH-FB1∆), RD domain (997 to 1545) (CHDH-RD∆) and FB2 
domain (1531 to 1722) (CHDH-FB2∆) based on the bioinformatic domain prediction 
using MITOPROT (http://ihg.gsf.de/ihg/mitoprot.html) and SUPERFAMILY 
Sequence Search (http://supfam.org/SUPERFAMILY/hmm.html). The HA-CHDH 
and CHDH-MYC-HIS were produced by subcloning CHDH into pcDNA3-HA and 
pEF1/MYC-HIS (Invitrogen, V92120), respectively. HA-CHDH-MYC-HIS was 
constructed by subcloning CHDH-MYC-HIS into pcDNA3-HA for HA tagging at the 
N terminus and MYC-HIS tagging at the C terminus. The SQSTM1-FL-MYC-HIS, 
SQSTM1-PB1∆-MYC-HIS were gifts from Dr. M. Tanaka (Kyoto Prefectural 
University, Japan) and PINK1-GFP was from Dr. J. Chung (Seoul National University, 
Korea). TOMM20-GFP, TOMM20-FB1-GFP and FB1-GFP were constructed by 
 
６ 
subcloning of TOMM20 and/or the FB1 domain cDNA into pEGFP-N1 (Invitrogen, 
6085-1). Rs12676 SNP mutant of CHDH (R78L) was generated by site-directed 
mutagenesis using PCR: The following primers were used. Fwd, 5 -́GCC CAA GGA 
CGT GCT CGC GGG GAG CAA GCG-3  ́and Rev, 5 -́CGC TTG CTC CCC GCG 
AGC ACG TCC TTG GGC-3 .́ The SQSTM1 siRNA was kindly provided by Dr. J. 
Shin (Sungkyunkwan University, Korea). 
 
2.3. Measurement of Mito-GFP intensities 
    After transfection with Mito-GFP, the fluorescence of cells was measured with 
EnVision multilabel plate reader (PerkinElmer, 940 Winter Street, Waltham, 02451, 
MA USA).  
 
2.4. Measurement of enzyme activity and LC-MS 
    Mitochondria were purified from cells using differential centrifugation as 
described previously.20 After resuspension in reaction buffer (10 mM sodium 
 
７ 
phosphate, 10 mM Tris-Cl, pH 8.0), mitochondria were burst by sonication and then 
mixed with 10 mM choline chloride and 2 mM phenazine methosulfate. The reaction 
was incubated at 37 °C for 1 h in the dark and samples were subjected to 
ultracentrifugation at 100,000 g for 30 min to precipitate mitochondrial debris; the 
supernatant fraction was kept at -70 °C until analysis. For LC-MS analysis, a Thermo-
Finnigan Surveyor instrument (Thermo Scientific, USA), equipped with autosampler 
and PDA-UV detector and Thermo-Finnigan LCQ Deca XP plus ion trap mass 
spectrometer with electrospray ionization interface was used. ZoRBAX 300SB-C8 
P/No. 865750-906, size 2.1 x 50 mm, 3.5 µm, S/No. USACR01562 was used for 
chromatographic separations. The injection volume was 10 µL and the mobile phase 
consisted of 0.1% formic acid in distilled water (A) and in acetonitrile (B). Gradient 
elution at a flow rate of 150 µL/min was as following: 95% (A) and 5% (B) from 0 to 
20 min, 5% (A) and 95% (B) from 20 min to 25 min, and returned to the initial 
condition from 20 min to 30 min. Total running time was 30 min. Ionization of 
analytes was carried out using electrospray ionization. The capillary temperature was 
 
８ 
maintained at 275 °C. The ion source voltage and the nebulizer gas were set at 5 kV 
and 30 units, respectively. The capillary voltage was at 46 V in positive and-15 V in 
negative ionization mode. The average scan time was 0.01 min while the average time 
for changing polarity was 0.02 min. The collision energy was generally chosen in 
order to maintain about 35% abundance of the precursor ion.  
 
2.5. Immunoprecipitation, western blot and antibodies 
    Immunoprecipitation and western blot analysis were performed as reported 
previously.51 Briefly, cells were lysed in lysis buffer (20 mM Tris-Cl, pH 7.6, 150 mM 
NaCl, 1% Triton X-100) and clarified by centrifugation. Cell lysates were 
dichotomized for immunoprecipitation and whole cell lysate quantification. For 
immunoprecipitaion, primary antibody was added overnight at 4 °C and pulled down 
by protein G Sepharose beads (GE Healthcare, 17-0618-01) at 4 °C for 1 h. Both 
samples were boiled in 1 X SDS sample buffer, separated by SDS-PAGE and 
transferred onto nitrocellulose membrane (Pall Corporation, 66485). After blocking 
 
９ 
with 5% skim milk in TBST, the membrane was incubated with the following 
antibodies: CHDH (Santa Cruz, sc-102442), TOMM20 (sc-17764), GFP (sc-8334), 
MYC (sc-40), TUBA/tubulin, alpha (sc-23948) and ACTB (sc-47778) SOD2 (Upstate, 
06-984), COX4I1 (Abcam, ab14744-100), SQSTM1 (Abnova, H00008878-M01 and 
Santa Cruz, sc-25575), PARK2 (Abcam, ab77924 and Santa Cruz, sc-32282), LC3 
(Novus, NB100-2220), FLAG (Sigma, F3165) and TIMM23 (BD Bioscience, 
611222). 
 
2.6. Immunofluorescence and colocalization coefficient 
    Cells were fixed with 4% paraformaldehyde and permeabilized with 0.005% 
digitonin in PBS (Gibco, 70011-044). After blocking with 10% fetal bovine serum, the 
fixed cells were incubated with antibodies at 1:100 to 1:250 dilution ratio, followed by 
incubation with Alexa Fluor secondary antibodies (Molecular Probes, A11005, 
A11001, A11008 and A11012). Samples were visualized under a confocal laser 
scanning microscope (Carl Zeiss, LSM700, Carl-Zeiss-Promenade 10, 07745, Jena 
 
１０ 
Germany) and colocalization coefficient was analyzed using ZEN software (Carl 
Zeiss). 
 
2.7. Flow cytometry 
    Cells were harvested and monocellized with Trypsin-EDTA, followed by fixation 
with 70% ethanol with voltexing and then subjected to analysis using a FACSCalibur 
flow cytometer (BD biosciences, 1 Becton Drive Franklin Lakes, 07417, NJ USA) 
according to the manufacturer’s instructions. 
 
2.8. Mitochondrial DNA quantification 
    Mitochondrial DNA was extracted using Exprep kit (GeneAll, 101-102) and 
subjected to PCR analysis using MT-CYB primers: Fwd, 5 -́TTC TGA GGG GCC 
ACA GTA ATT ACA AAC TTA-3 ,́ Rev, 5 -́ATG GAG GAT GGG GAT TAT TGC 
TAG GAT GAG-3 .́ Prior to mitochondrial DNA extraction, whole cell DNA was also 
extracted for quantification as described previously52 and subjected to PCR analysis 
 
１１ 
using ACTB primers: Fwd, 5 -́CGT TGG CAT CCA CGA AAC TA-3 ,́ Rev, 5 -́AGT 
ACT TGC GCT CAG GAG GA-3 .́  
 
2.9. Mitochondria fractionation 
    Cells were resuspended in PBS and subjected to sonication twice at 30% 
amplitude for 3 sec with an Ultrasonic Processor 130 W (Sonics & Materials, 53 
Church Hill Road, Newtown, 06470-1614, CT USA). Unbroken cells and nuclei were 
removed by centrifugation at 1,000 g for 10 min. The postnuclear supernatant fraction 
was pelleted by further centrifugation at 10,000 g for 15 min to obtain the 
mitochondria pellet. For submitochondria fractionation, the pelleted mitochondria 
were rinsed with swelling buffer (10 mM KH2PO4, pH 7.4) once and resuspended in 
swelling buffer for 20 min with gentle mixing, followed by addition of an equal 
volume of shrinking buffer (10 mM HEPES, pH 7.4, 32% sucrose, 30% glycerol, 10 
mM MgCl2) for 15 min. Subsequent centrifugation at 10,000 g for 15 min yielded the 
pelleted mitoplast and suspended OM and intermembrane space (IMS) fraction which 
 
１２ 
was kept for further separation.  The mitoplast was rinsed twice with washing buffer 
(250 mM sucrose, 1 mM EGTA, 10 mM HEPES, pH 7.4), resuspended in swelling 
buffer and burst 5 times by sonication at 50% amplitude for 3 sec. this suspension was 
centrifuged at 12,000 g for 15 min to discard the unbroken mitoplast. Finally, samples 
were processed by ultracentrifugation at 100,000 g for 40 min to separate OM and 
IMS fractions, and the IM matrix fractions. Every procedure was performed at 4 °C. 
 
2.10. Proteinase K degradation assay 
    For proteinase K degradation assay, the purified mitochondria were resuspended 
in PK assay buffer (20 mM HEPES, pH 7.4, 250 mM sucrose, 80 mM potassium 
acetate, 5 mM magnesium acetate) and added with proteinase K (GenDepot, P2170-








3.1. CHDH is required for PARK2-mediated mitophagy  
First, I examined the necessity of CHDH for mitophagy induced by carbonyl 
cyanide m-chlorophenylhydrazone (CCCP), a mitochondrial uncoupler that triggers 
mitochondrial depolarization and mitophagy.25 By using CHDH shRNA, I generated 
stable HeLa cells that showed reduced expression of CHDH (HeLa-shCHDH cells) 
(Fig. 1B, upper). As has been previously reported26, immunofluorescence analysis 
revealed that CCCP treatment induced the degradation of TOMM20-positive 
mitochondria in the presence of PARK2 in control HeLa cells (Fig. 1A, left), which 
contain no endogenous PARK2. However, knockdown of CHDH expression impeded 
the degradation of mitochondria (Fig. 1A, right). Mitochondrial degradation did not 
occur in the absence of PARK2, consistent with the previous report.11, 27 When flow 
cytometry analysis was employed to measure the total fluorescence intensity of Mito-
RFP, the results of CCCP exposure showed that clearance of Mito-RFP-positive 
 
１４ 
mitochondria was also retarded in HeLa-shCHDH cells (Fig. 2A). Similarly, 
quantification of the degradation of mitochondrial DNA and proteins revealed that 
quantities of MT-CYB/cytochrome b DNA and mitochondrial proteins, such as 
SOD2/MnSOD and TOMM20, were less reduced in HeLa-shCHDH cells than in 
control cells during mitophagy (Fig. 2B, C). These results indicate that CHDH is 
required for the proper functioning of PARK2-mediated mitophagy in HeLa cells.  
Given that PARK2-mediated mitophagy is related to PD, I also examined the role 
of CHDH in mitophagy of SN4741 neuronal cells, a clonal substantia nigra 
dopaminergic neuronal murine cell line which expresses PARK2.28 Using western blot 
analysis, I confirmed the expression of PARK2 in SN4741 cells (data not shown). 
Exposure of SN4741 cells to CCCP resulted in clearance of Mito-RFP-positive 
mitochondria (Fig. 2D, E). On the contrary, knockdown of CHDH expression 
significantly impaired the clearance of Mito-RFP-positive mitochondria in SN4741 
cells (Fig. 2D, E), suggesting that CHDH is required for PARK2-mediated mitophagy 
not only in HeLa cells but also in SN4741 dopaminergic neuronal cells. 
 
１５ 
I also examined the effect of CHDH overexpression on mitophagy. When HeLa 
cells expressing PARK2 were exposed to CCCP, colocalization of GFP-LC3 and 
Mito-RFP was enhanced by CHDH overexpression (Fig. 3A). Interestingly, CHDH 
overexpression followed by CCCP treatment also increased the colocalization of 
mitochondria and LC3. When I analyzed mitochondrial DNA and protein quantities 
following CCCP treatment, I found that clearance of MT-CYB DNA and mitochondrial 
COX4I1/COX-IV protein was accelerated by CHDH overexpression (Fig. 3B, C). 
Consistent with this result, the fluorescence intensity of Mito-GFP was rapidly 
dissipated by CHDH overexpression in HEK293T cells during mitophagy, which is 
almost equivalent to that by PINK1 overexpression (Fig. 3D). These results indicate 
that CHDH overexpression enhances CCCP-induced clearance of mitochondria. 
However, expression level of CHDH did not affect the stability of PINK1 protein, 
although CCCP treatment stabilized PINK1 in mitochondria as previously reported 
(Fig. 4A, B).29, 30 In addition, PINK1 knockdown attenuated CCCP-induced 
mitophagy in both control cells and cells overexpressing CHDH. However, the 
 
１６ 
overexpression of CHDH still enhanced mitophagy in PINK1 knockdown cells (Fig. 
4C). 
 
3.2. Mitophagic activity of CHDH is independent of enzyme activity 
I next examined whether this mitophagic activity of CHDH is related to its 
enzymatic activity that converts choline to betaine aldehyde. I constructed a series of 
CHDH deletion mutants based on bioinformatic analysis (materials and methods). 
CHDH appears to have a mitochondria-targeting sequence at its N-terminus (residues 
1 to 38) and three functional domains, named FAD/NAD(P)-binding domain 1 (FB1, 
residues 39 to 326), FAD-linked reductase domain (RD, residues 333 to 515) and 
FAD/NAD(P)-binding domain 2 (FB2, residues 511 to 574) (Fig. 5). Expression of 
these constructs was confirmed by western blot analysis (Fig. 6A). Overexpression of 
the CHDH-RD∆ or CHDH-FB2∆ mutants induced colocalization of GFP-LC3 with 
Mito-RFP as effectively as wild-type CHDH, but the CHDH-FB1∆ mutant failed to 
do so (Fig. 6B, Fig. 7A), indicating that the FB1 domain of CHDH is critical for its 
 
１７ 
mitophagy-stimulating activity. However, enzyme activity assays using these mutants 
illustrated that all of these CHDH mutants exhibited impaired activity of the enzyme 
that generates betaine aldehyde; the FB1 and FB2 domains were crucial for this 
activity, as was the RD domain, which was less important but still required (Fig. 7B). 
Further, when I tested the mitophagic activity of betaine, the product of CHDH and 
betaine aldehyde dehydrogenase, which is involved in many biochemical pathways,31 
I discovered that betaine did not affect the colocalization of LC3 with mitochondria 
(Fig. 8). Overall, it appears that the mitophagy-stimulating function of CHDH is 
independent of its well-known enzymatic activity and enzymatic product.  
 
3.3. CHDH accumulates on the outer membrane following mitochondrial 
damage 
I next investigated the subcellular location of CHDH. Consistent with the 
previous reports,32, 33 I found that CHDH was present in mitochondria (Fig. 9A). I 
further assessed the submitochondrial location of CHDH using a submitochondrial 
 
１８ 
fractionation assay (Fig. 9B). CHDH and the outer membrane (OM)-located 
TOMM20 were detected in the OM fraction, as well as in the IM fraction, in which 
COX4I1 was also located (Fig. 9B). However, CHDH was not detected in the cytosol 
and matrix fractions. To confirm this result, I purified mitochondria from HeLa and 
HEK293T cells and performed a proteinase K (PK) degradation assay. Incubation of 
the purified mitochondria with the increased concentrations of PK resulted in gradual 
degradation of CHDH and TOMM20, but it did not affect the levels of SOD2 in the 
matrix or IM-localized COX4I1 (Fig. 9C). Whereas the previous study proposed that 
CHDH is located on the IM of mitochondria, these results indicate that CHDH is 
present on both the OM and IM of mitochondria. According to the western blot 
analysis showing that CHDH was retained in the membrane-associated fractions after 
the treatment with high salt (Fig. 10A), I believe that CHDH is present as a 
transmembrane protein in the mitochondria. 
Next, I compared the quantity of CHDH on the OM and IM of mitochondria 
following CCCP treatment. Instead of using the conventional concentration (10 to 20 
 
１９ 
µM) of CCCP, which induces mitochondrial membrane potential dissipation but may 
interfere with membrane integrity and thus result in marker protein contamination in 
PK and fractionation assays, I used a lower concentration of CCCP that would induce 
mild mitochondrial depolarization but not affect membrane integrity during the assays. 
To determine the required concentration, I assessed different concentrations of CCCP, 
ranging from 0.01 to 10 µM of CCCP, in pilot experiments and found that 0.1 µM 
CCCP was sufficient to induce significant depolarization of the mitochondrial 
membrane (Fig. 10B). Using this concentration of CCCP, I found that in mitochondria 
isolated from CCCP-treated cells, CHDH was more sensitive to degradation by PK 
than it was in mitochondria isolated from untreated control cells (Fig. 11A). I thus 
hypothesized that CHDH accumulates on the OM of mitochondria following the loss 
of the mitochondrial membrane potential. A subsequent fractionation assay also 
showed that CCCP treatment induced the accumulation of CHDH in the OM fraction, 
with a concomitant reduction of CHDH in the IM fraction (Fig. 11B, C). I also 
performed an assay using cycloheximide to block protein translation, which showed 
 
２０ 
that CHDH accumulated on the OM of mitochondria in the presence of cycloheximide 
(Fig. 11B), indicating that the accumulation of CHDH on the OM of mitochondria 
does not result from de novo protein synthesis.  
When I assessed the topology of CHDH in the mitochondrial membrane, a PK 
assay following the expression of N-terminal-tagged CHDH (HA-CHDH) revealed 
that the N terminus of CHDH may be exposed to the cytosol in control cells (Fig. 
12A). I confirmed this result with immunocytochemical analysis. In a control analysis, 
an immunofluorescence assay following differential permeabilization of cells revealed 
that the immunofluorescent signal of TOMM20, but not SOD2, was detectable by 
mild permeabilization using 0.001% digitonin. In contrast, immunofluorescence of 
both TOMM20 and SOD2 were observed after permeabilization with 0.05% Triton X-
100, which permeabilizes both the plasma membrane and the mitochondrial 
membrane (Fig. 12B, upper). Identical experiments were then performed following 
the expression of dual-tagged HA-CHDH-MYC-HIS containing HA at the N terminus 
and MYC-HIS at the C terminus. In contrast to the N-terminal HA, 
 
２１ 
immunofluorescence of the C-terminal HIS was not observed after permeabilization 
with 0.001% digitonin but observed with Triton X-100 (Fig. 12B, lower). These 
results suggest that the N terminus of OM-located CHDH is exposed to the cytosolic 
side, whereas the C terminus is located inside mitochondria in both control and 
CCCP-treated cells. Further, western blot analysis using CHDH antibody recognizing 
the C terminus revealed that approximately 45-kDa cleavage product of CHDH 
appeared in a PK assay of purified mitochondria and its amount was increased by 
CCCP treatment in SH-SY5Y cells (Fig. 12C). Thus, approximately a 20-kDa N-
terminal region of CHDH is exposed to the cytosol.  
To further assess the mechanism by which CHDH translocates across the 
mitochondrial membranes, I hypothesized that the mitochondrial OM–IM contact site 
was a candidate site for the CHDH path. Because the VDAC1-adenine nucleotide 
translocator (ANT) complex is one of the contact sites,34 I tested whether VDAC1 
functions as a path for CHDH during mitophagy. Interestingly, I found that CHDH 
interacted with VDAC1 following CCCP treatment (Fig. 13A). Moreover, compared 
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to controls, overexpression of VDAC1 increased PK-sensitive cleavage of CHDH 
during mitophagy (Fig. 13B), indicating that the accumulation of CHDH on the OM is 
enhanced by VDAC1. Thus, the VDAC1-ANT complex may function to regulate the 
accumulation of CHDH in the OM of mitochondria during mitophagy. On the other 
hand, this accumulation was not affected by the overexpression of PLSCR3 
(phospholipid scramblase 3) (Fig. 13C), which plays a role in the externalization of 
cardiolipin to the OM of mitochondria during mitophagy.35 Also, total amount of 
CHDH protein was not changed during mitophagy or by PINK1 knockdown (Fig. 
13D). 
 
3.4. CHDH interacts with SQSTM1 independently of PARK2 during mitophagy 
Because knockdown of CHDH expression resulted in reduced colocalization of 
LC3 with mitochondria (Fig. 8), I hypothesized that CHDH may affect the cargo 
recognition step in mitophagy via SQSTM1, an important adaptor that connects 
damaged cargo to LC3.36, 37 Using immunoprecipitation analysis,I observed that 
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CHDH interacted with SQSTM1 in the transfected cells (Fig. 14A). Interestingly, this 
interaction remarkably increased in cells following CCCP treatment. Similarly, 
endogenous CHDH bound to SQSTM1 in SH-SY5Y neuronal cells and this 
interaction also increased following exposure to CCCP; the interaction reached a 
maximum level at 30 min and remained high up to 240 min (Fig. 14B). However, 
CHDH did not interact with other mitochondrial proteins, such as TOMM20 and 
COX4I1. I confirmed the endogenous interaction using a reciprocal 
immunoprecipitation assay (Fig. 14C).  
I then addressed whether this interaction was dependent on PARK2 in HeLa cells. 
Although PARK2 expression is absent in HeLa cells, a basal level of the interaction 
between CHDH and SQSTM1 was also detected in HeLa cells, and this interaction 
increased following CCCP treatment (Fig. 15A). However, the interaction was 
impaired in HeLa-shCHDH cells compared to control HeLa cells. Moreover, the 
overexpression of PARK2 in HeLa cells did not affect the interaction (Fig. 15B), 
indicating that the binding of CHDH to SQSTM1 is independent of PARK2. Further, 
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when I examined PARK2-mediated ubiquitination of mitochondrial proteins during 
mitophagy, I observed the ubiquitination of VDAC1, a substrate of PARK2,26 but not 
of CHDH (Fig. 15C), indicating that CHDH is not a substrate of PARK2. 
Next, I determined the domains responsible for the interaction between CHDH 
and SQSTM1 using deletion mutants (Fig. 5 and 16A). The results of an 
immunoprecipitation assay showed that, unlike full-length SQSTM1, a SQSTM1-
PB1∆ mutant lacking the PB1 domain, which is responsible for its interaction with 
certain aggregate-prone mutant proteins,38, 39 failed to interact with CHDH in 
HEK293T cells (Fig. 16B, C). I also determined the binding region of CHDH and 
observed that the CHDH-FB1∆ mutant lacking an FB1 domain did not interact with 
SQSTM1 (Fig. 16D). These results suggest that the PB1 domain of SQSTM1 and the 
FB1 domain of CHDH are required for their interaction. I confirmed these results 
using a colocalization assay under a confocal microscope. Unlike wild-type CHDH, 
mutant CHDH-FB1∆ did not colocalize with SQSTM1 in cells before or after CCCP 
treatment (Fig. 17A). Expression of CHDH or CHDH-FB1∆ did not affect the 
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function of PARK2, as examined by VDAC1 ubiquitination (Fig. 17B). SNPs of 
CHDH, especially rs12676 (G233T; R78L), which is located in the FB1 domain, are 
known to be responsible for mitochondrial function and morphology in mice and 
humans, especially in sperm.6, 9 When this SNP was examined for its ability to interact 
with SQSTM1, there was no significant difference between CHDH wild-type and 
rs12676 (Fig. 17C). 
 
3.5. The interaction of CHDH with SQSTM1 brings LC3 to damaged 
mitochondria for cargo recognition during mitophagy 
To investigate the functional significance of the interaction between CHDH and 
SQSTM1 during mitophagy, I examined knockdown effects of CHDH expression on 
SQSTM1 recruitment into impaired mitochondria. Compared to HeLa control cells, 
colocalization between Mito-RFP and SQSTM1 was abrogated in HeLa-CHDH 
knockdown cells during mitophagy (Fig. 18A, B). In addition, a mitochondrial 
fractionation assay illustrated that SQSTM1 was dramatically recruited into the 
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mitochondrial fraction as early as 15 min after CCCP treatment in SH-SY5Y cells and 
resided in mitochondria for up to 60 min (Fig. 19A). Strikingly, this recruitment was 
much reduced in SH-SY5Y-CHDH knockdown cells. However, CHDH did not affect 
the recruitment of PARK2 into mitochondria. To further investigate the recruitment of 
SQSTM1 to damaged mitochondria, I performed a fractionation assay. Compared to 
untreated control cells, CCCP treatment increased the quantity of mitochondrial 
fraction-localized SQSTM1 in HEK293T cells overexpressing CHDH, but not in cells 
expressing the SQSTM1 binding-defective CHDH-FB1∆ mutant (Fig. 19B).I also 
found that the degradation of mitochondrial proteins during mitophagy was partially 
but significantly impaired by SQSTM1 knockdown in HEK293T cells (Fig. 19C). 
These observations suggest that CHDH is required for the recruitment of SQSTM1 
into damaged mitochondria for degradation. 
Further, confocal imaging analysis revealed that the colocalization of GFP-LC3 
and Mito-RFP was decreased by 2-fold in HeLa-shCHDH cells compared to HeLa 
control cells (Fig. 20A). This reduction in the colocalization was also observed in 
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HeLa control cells lacking PARK2 (Fig. 20A, lanes 2 and 6). It thus appears that 
CHDH recruits LC3 independently of PARK2, as was observed in the SQSTM1-
binding pattern of CHDH. Given that SQSTM1 directly links damaged and 
ubiquitinated mitochondria to LC3,36 I examined protein complex formation among 
CHDH, SQSTM1 and LC3. The results of an immunoprecipitation assay showed that 
CHDH, but not CHDH-FB1∆, formed a protein complex with SQSTM1 and LC3 in 
HeLa cells following CCCP treatment (Fig. 20B). Under identical conditions, 
knockout of SQSTM1 expression prevented formation of the ternary protein complex 
containing LC3 and CHDH (Fig. 20C). Because an LC3-containing autophagosome 
fused with a lysosome is destined for degradation, I then examined the relative effects 
of CHDH and CHDH-FB1∆ on PARK2-dependent degradation of mitochondria. 
Immunofluorescence analysis revealed that CHDH-FB1∆ was less effective than 
CHDH to clear TOMM20-positive mitochondria following CCCP treatment (40.8% 
vs. 60.5%) (Fig. 20D). These results suggest that CHDH binds to SQSTM1 to bring 
LC3 to the damaged mitochondria for the degradation of mitochondria and is 
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indispensable for PARK2-mediated mitophagy at the cargo-recognition step. 
Based on the domain mapping results for CHDH, I asked whether the CHDH 
FB1 domain is sufficient for LC3 recruitment into mitochondria. I generated a 
TOMM20-FB1-GFP chimera, a mitochondrial OM-targeting chimeric construct 
containing TOMM20 fused to CHDH FB1-GFP (Fig. 21A, upper), and examined its 
ability to recruit LC3 into the mitochondria under a confocal microscope. When these 
constructs were overexpressed in HeLa cells, no difference was observed between 
TOMM20-GFP and TOMM20-FB1-GFP in the recruitment of mRFP-LC3 into 
mitochondria. However, when cells were exposed to CCCP, TOMM20-FB1-GFP 
increased colocalization of mRFP-LC3 with the mitochondria by 2-fold, compared to 
TOMM20-GFP (Fig. 21A, lower). These observations suggest that the CHDH FB1 
domain is necessary for LC3 recruitment to damaged mitochondria. 
In addition, I addressed whether the interaction between CHDH and SQSTM1 is 
critical for mitophagy using a competition assay. I found that FB1-GFP could bind to 
SQSTM1 in the transfected cells during mitophagy, although the interaction appears to 
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be weak (Fig. 21B). Moreover, ectopic expression of FB1-GFP weakened the 
interaction between CHDH and SQSTM1 in a dose-dependent manner. I then assessed 
the effect of FB1-GFP on mitochondrial clearance during mitophagy. 
Immunofluorescence analysis revealed that ectopic expression of FB1-GFP 
significantly inhibited PARK2-dependent clearance of TOMM20-positive 
mitochondria during CCCP-induced mitophagy (from 51.8% to 19.0%) (Fig. 22A, B). 
Consistently, FB1-GFP colocalized with SQSTM1-MYC in the transfected cells (Fig. 
22C). These results suggest that the interaction between CHDH and SQSTM1 is 
important for mitophagy to proceed. 
 
3.6. CHDH is implicated in MPP+-induced mitophagy in SN4741 dopaminergic 
cells 
The failure of appropriate recognition of damaged mitochondria causes 
accumulation of defective mitochondria11, 26 and this failure is closely associated with 
the pathogenesis of PD.40 In SN4741 dopaminergic cells, I thus addressed the role of 
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CHDH during mitophagy triggered by 1‑methyl‑4‑phenylpyridinium (MPP+), a 
Parkinsonism-causing reagent.41 Like CCCP, treatment with MPP+ induced a 
significant level (30.0%) of colocalization of GFP-LC3 with mitochondria in SN4741 
cells (Fig. 22D). In contrast, downregulation of CHDH expression abolished the 
colocalization (8.5%). These results indicate that CHDH is essential in the mitophagy 





Figure 1. CHDH is required for CCCP-induced mitophagy.  
(A, B) HeLa-Control (Ctrl) and HeLa-CHDH knockdown (HeLa-shCHDH) stable 
cells were transfected with FLAG-Ctrl or FLAG-PARK2 and then exposed to DMSO 
or 10 µM CCCP for 24 h. After staining with TOMM20 antibody and Hoechst 33258 
dye, cells were examined under a confocal microscope. Scale bar = 10 µM (A). 
Expression of CHDH in HeLa-Ctrl and HeLa-shCHDH cells was assessed using 
western blot analysis (B, upper). The signal intensity of TOMM20 in HeLa-Ctrl and 
HeLa-shCHDH cells (n > 50) exposed to CCCP and expressing PARK2 in (A) were 
quantified using the ImageJ program and are represented as bars with the mean ± S.D, 






Figure 2. CHDH is required for CCCP-induced and PARK2-mediated 
mitophagy. 
(A) HeLa-Ctrl and HeLa-shCHDH cells were transfected with PARK2 and Mito-RFP 
and treated with DMSO or 10 µM CCCP. After 24 h, cells were fixed and subjected to 
flow cytometry analysis, as described in the materials and methods.  
(B, C) HeLa-Ctrl and HeLa-shCHDH cells were transfected with PARK2 and then 
left untreated or exposed to 10 µM CCCP for 24 h. Mitochondrial DNA and proteins 
were extracted and subjected to PCR analysis using synthetic primers for cytochrome 
b (MT-CYB) and ACTB (D), and western blot analysis using SOD2 and TOMM20 
antibodies (C), respectively.  
(D, E) SN4741 cells were transiently transfected with Mito-RFP and either pSuper 
(Ctrl) or CHDH shRNA and then exposed to DMSO or 20 µM CCCP. After 24 h, cells 
were stained with Hoechst 33258 dye and examined under a confocal microscope. 
Scale bar = 10 µM (D). The signal intensities of Mito-RFP in CCCP-treated control 
and CHDH knockdown cells were quantified as in (Fig. 1B) and are represented as % 
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of cells (n > 50) with cleared mitochondria. Bars represent the mean ± S.D. * P < 






Figure 3. Overexpression of CHDH accelerates mitochondrial clearance. 
(A) HeLa-Ctrl and HeLa-CHDH cells were cotransfected with GFP-LC3, Mito-RFP 
and either GFP control vector (Ctrl) or PARK2 and then incubated with 10 µM CCCP. 
After 2 h, cells were analyzed under a confocal microscope; the colocalization 
coefficient (%) of GFP-LC3 and Mito-RFP is shown with bars representing the mean 
± S.D (n > 50). * P < 0.001.  
(B, C) HeLa-Ctrl and HeLa-CHDH cells were left untreated or exposed to 10 µM 
CCCP for 30 h (B) or for the indicated times (C). Mitochondrial DNA (MT-CYB) and 
proteins (CHDH, COX4I1) were extracted and analyzed by PCR (B) and western 
blotting (C), respectively.  
(D) HEK293T cells were cotransfected with Mito-GFP and pcDNA (Ctrl), CHDH + 
PARK2 or PINK1 + PARK2. Following treatment with DMSO or 100 µM CCCP for 
2 h, the fluorescence of cells was measured, as described in the materials and methods. 
The signal of Mito-GFP in control extracts is fixed as 100 and the relative ratio to the 






Figure 4. Effects of CHDH expression on PINK1-mediated mitophagy. 
(A) HeLa-Ctrl and HeLa-CHDH cells were cotransfected with PINK1-GFP and Mito-
RFP and then exposed to 10 µM CCCP for 2 h, after which cells were examined under 
a confocal microscope.  
(B) HeLa-control (Ctrl), CHDH overexpression (OE) and shCHDH knockdown (KD) 
stable cells were exposed to 10 µM CCCP for 2 h. Cell extracts were analyzed with 
western blotting.  
(C) SN4741 control (Ctrl) and PINK1 knockdown stable cells were transfected with 
CHDH, Mito-RFP and control GFP for 24 h and then left untreated or treated with 20 
µM CCCP for 24 h. Mito-RFP-negative cells among total GFP-positive cells were 






Figure 5. Schematic of CHDH full-length (FL) and deletion mutants (FB1∆, RD∆, 







Figure 6. Effects of CHDH deletion mutants on mitophagy.  
(A) HeLa cells were transfected with CHDH deletion mutants and then subjected to 
western blot analysis using MYC antibody.  
(B) HeLa cells were transfected with GFP-LC3, Mito-RFP and either CHDH-FL or 
deletion mutants, and then analyzed under a confocal microscope at 4 h after treatment 






Figure 7. Mitophagic activity of CHDH is independent of its enzymatic activity. 
(A) The colocalization coefficient (%) of GFP-LC3 and Mito-RFP in the presence of 
CHDH-FL or deletion mutants was analyzed in the transfected cells under a confocal 
microscope and is represented as a bar graph with the mean ± S.D. Cells were treated 
with 10 µM CCCP for 4 h. * P < 0.001 (n > 50). 
(B) HEK293T cells were transfected with CHDH or a series of deletion mutants and 
then subjected to LC-MS for measurement of enzyme activities, as described in the 






Figure 8. Betaine shows little effect on CHDH-mediated mitophagy. 
HeLa-Ctrl and HeLa-shCHDH cells were cotransfected with PARK2, Mito-RFP and 
GFP-LC3 and then left untreated or exposed to 1 mM betaine for 2 h. After treatment 
with 20 µM CCCP for 2 h, cells were observed under a confocal microscope. The 
colocalization coefficient (%) between Mito-RFP and GFP-LC3 is represented as bars 







Figure 9. CHDH resides on the IM and OM of mitochondria. 
(A) HeLa cells were transfected with CHDH-MYC-HIS and Mito-RFP, followed by 
immunofluorescence analysis using MYC antibody (green) under a confocal 
microscope. 
(B) HEK293T cells were subjected to submitochondrial fractionation analysis, as 
described in the materials and methods, and the fractions were verified using western 
blot analysis using the indicated antibodies. 
(C) Mitochondria isolated from HeLa and HEK293T cells were treated with the 
increasing concentrations (0.25, 0.5, 0.75, 1, and 2 µg/mL) of proteinase K, and the 












Figure 10. Property of CHDH and effect of CCCP on mitochondrial membrane 
potential.                                                            
(A) Pure mitochondria isolated from HEK293T cells were burst by sonication, 
incubated with Tris buffer (pH 8.0) containing 500 mM NaCl (left) or 1% Triton X-
100 (right) for 30 min and then separated into the membrane-associated pellet (Pel) 
and soluble supernatant (Sup) fractions by ultracentrifugation. The fractions were 
analyzed by western blotting. Cytochrome c (CYCS) was used as a control of soluble 
proteins.                                                               
(B) HeLa cells were incubated with 100 nM TMRE for 20 min. After washing out the 
remaining dye with PBS, cells were treated for 30 min with the indicated 
concentrations of CCCP. Signal intensity of TMRE under a confocal microscope was 







Figure 11. CHDH resides on the IM and OM of mitochondria and is enriched in 
the OM following CCCP treatment.  
(A to C) Following treatment of HEK293T cells with 0.1 µM CCCP for 30 min, 
mitochondria were purified and treated with Proteinase K (1 µg/mL), and the reaction 
products were analyzed using western blotting (A). HEK293T cells were pretreated 
with cycloheximide (CHX, 20 µg/mL) for 3 h and then exposed to 0.1 µM CCCP for 
30 min, followed by submitochondrial fractionation and western blot analysis (B). The 
normalized relative ratio of CHDH signals detected in the OM and IM fractions on the 
blots in the (B) control group was determined by densitometric analysis using the 









Figure 12. Topology of CHDH.  
(A) HeLa cells were transfected with HA-CHDH and treated with the annotated 
concentrations of CCCP for 30 min. Then, pure mitochondria were prepared and 
subjected to a proteinase K assay. 
(B) HeLa cells were left untreated (Ctrl) or transfected with HA-CHDH-MYC-HIS. 
After permeabilization with 0.001% digitonin or 0.05% Triton X-100, cells were 
coimmunostained with TOMM20 (mouse/red) and SOD2 (rabbit/green) antibodies to 
confirm partial permeabilization (Ctrl) or with HA (mouse/red) and HIS (rabbit/green) 
antibodies (HA-CHDH-MYC-HIS) and then visualized under a confocal microscope. 
TUBA, tubulin, alpha.  
(C) After treatment of SH-SY5Y cells with the increasing concentrations of CCCP 
(0.1 to 1 µM), mitochondria were purified, subjected to a proteinase K assay and 
analyzed by western blotting using CHDH antibody recognizing the C terminus. 






Figure 13. Accumulation of CHDH on the mitochondrial outer membrane by 
HA-VDAC1.  
(A) HEK293T cells were transfected with HA-VDAC1 and treated with 1 µM CCCP 
for 30 min. Following immunoprecipitation (IP) with HA-antibody, the 
immunoprecipitates and whole cell lysates (WCL) were analyzed by western blotting.  
(B) After treatment of HEK293T cells with 0.1 µM CCCP for 30 min, cell extracts 
were subjected to a proteinase K assay and then analyzed by western blotting.  
(C) After transfection with PLSCR3, HEK293T cells were left untreated or treated 
with 0.1 µM CCCP for 30 min. Cell extracts were subjected to proteinase K assay and 
then analyzed by western blotting (left). The expression of PLSCR3 was confirmed by 
RT-PCR (right).  
(D) SN4741-Ctrl and PINK1 knockdown cells were treated with 10 µM CCCP for 2 h 









Figure 14. CHDH binds to SQSTM1. 
(A) HEK293T cells were transfected with pcDNA (Ctrl) or HA-CHDH and then left 
untreated or treated with 10 µM CCCP for 30 min. Cell extracts were prepared and 
subjected to immunoprecipitation (IP) analysis using a CHDH antibody. The 
immunoprecipitates and whole cell lysates (WCL) were analyzed by western blotting.  
(B and C) SH-SY5Y cells were treated with 20 µM CCCP for the indicated times (B) 
or for 30 min (C). Cell extracts were subjected to immunoprecipitation (IP) analysis 
using preimmune normal (Nor) and CHDH antibody (B) or SQSTM1 antibody (C). 






Figure 15. Interaction between CHDH and SQSTM1. 
(A) HeLa-Ctrl and HeLa-shCHDH cells were left untreated or treated with 10 µM 
CCCP for 5 h and cell extracts were subjected to immunoprecipitation (IP) analysis 
using CHDH antibody. 
(B) HeLa-Ctrl and HeLa-shCHDH cells were transfected with FLAG-Ctrl or FLAG-
PARK2 and then left untreated or exposed to 20 µM CCCP for 30 min. Cell extracts 
were subjected to immunoprecipitation (IP) analysis using a CHDH antibody. The 
asterisk indicates a heavy chain that is weakly bound across species. 
(C) HeLa cells were transfected with HA-VDAC1, CHDH and either control vector or 
PARK2 as indicated, and then treated with 10 µM CCCP for 3 h in the presence or 






Figure 16. CHDH binds to SQSTM1, which requires the CHDH FB1 and 
SQSTM1 PB1 domains.  
(A) A schematic representation of SQSTM1 full-length (FL) and the PB1-deletion 
mutant (PB1∆).  
(B, C) HEK293T cells were transfected with SQSTM1-FL-MYC-HIS or SQSTM1-
PB1∆-MYC-HIS and then treated with 20 µM CCCP for 30 min, after which cell 
lysates were subjected to immunoprecipitation (IP) analysis using CHDH antibody (B, 
upper) or MYC antibody (C, upper). The immunoprecipitates and whole cell lysates 
(WCL) were analyzed by western blotting (lower).  
(D) HEK293T cells were transfected with CHDH-MYC and its deletion mutants and 
then treated with 10 µM CCCP for 30 min, after which cell lysates were subjected to 







Figure 17. CHDH- FB1∆ on mitophagy. 
(A) HeLa cells were transfected with CHDH-FL-MYC-HIS or CHDH-FB1∆-MYC-
HIS and then exposed to 20 µM CCCP for 3 h. Cells were examined with 
immunofluorescence analysis using MYC and SQSTM1 antibodies. Scale bar = 10 
µM. Enlarged sections are shown on right side with labelling (a to d).  
(B) HeLa cells were transfected with HA-VDAC1, PARK2 and either CHDH-FL or 
FB1∆ for 24 h and incubated with 20 µM CCCP for 2 h. Cell extracts were analyzed 
by western blotting.  
(C) HEK293T cells were transfected with CHDH wild-type (WT) or rs12676 SNP 
containing CHDH-R78L and then incubated with 20 µM CCCP for 30 min. Samples 
were immunoprecipitated (IP) with preimmune normal (Nor) or CHDH antibody 






Figure 18. CHDH recruits SQSTM1 onto mitochondria during mitophagy.  
(A, B) HeLa-Ctrl and HeLa-shCHDH cells were transfected with Mito-RFP and 
FLAG-PARK2 and treated with 10 µM CCCP for 4 h. Following immunostaining 
with a SQSTM1 antibody, cells were examined under a confocal microscope (A) and 
the colocalization coefficient (%) of SQSTM1 and Mito-RFP was determined. Bars 











Figure 19. CHDH recruits SQSTM1 onto mitochondria during mitophagy. 
(A) SH-SY5Y-Ctrl and SH-SY5Y-shCHDH stable cells were treated with 20 µM 
CCCP for the indicated times and mitochondria were purified and analyzed by 
western blotting using the indicated antibodies.  
(B) HEK293T cells were transfected with CHDH-FL or CHDH-FB1∆ and then 
treated with 10 µM CCCP for the indicated times. Cell extracts were fractionated to 
isolate mitochondria followed by western blot analysis. 
(C) HEK293T cells were transfected with scrambled siRNA (Scr) or SQSTM1 siRNA 
for 48 h. After treatment with 10 µM CCCP for 24 h, cell extracts were prepared and 










Figure 20. Interaction of CHDH with SQSTM1 increases the recruitment of LC3 
into mitochondria to process mitophagy.  
(A) HeLa-Ctrl and HeLa-shCHDH cells were cotransfected with GFP-LC3, Mito-RFP 
and either control vector (Ctrl) or PARK2. Following treatment with DMSO or 10 µM 
CCCP for 4 h, cells were fixed and observed under a confocal microscope. The 
colocalization coefficient (%) of GFP-LC3 and Mito-RFP was determined and bars 
represent the mean ± S.D. * P < 0.005 (n > 50).  
(B) After HeLa cells were transfected with CHDH-FL-MYC-HIS or CHDH-FB1∆-
MYC-HIS and treated with 10 µM CCCP for 30 min, samples were subjected to an 
immunoprecipitation (IP) assay using preimmune (Nor) or a MYC antibody. The 
asterisk indicates the heavy chain of the MYC antibody.  
(C) sqstm1 KO MEF cells were exposed to 10 µM CCCP for 30 min. Cell extracts 
were subjected to an immunoprecipitation (IP) assay using a CHDH antibody and the 
immunoprecipitates and whole cell lysates (WCL) were analyzed by western blot.  
(D) HeLa cells were cotransfected with PARK2-GFP and either CHDH or CHDH-
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FB1∆, treated with 10 µM CCCP for 24 h and then immunostained with a TOMM20 
antibody. The percentage of cells showing reduced immunoreactivity against 
TOMM20 was determined using a confocal microscope and is represented as bars ± 









Figure 21. Mitochondrial targetting of FB1 domain enhances mitophagy.  
(A) Schematic diagram of TOMM20-FB1-GFP chimera (upper). HeLa cells were 
transfected with mRFP-LC3 and either TOMM20-GFP or TOMM20-FB1-GFP and 
exposed to 10 µM CCCP for 1 h. Cells were analyzed under a confocal microscope 
and the colocalization coefficient was determined. Bars represent the mean ± S.D. * P 
< 0.0001 (lower) (n > 50).  
(B) HEK293T cells were transfected with different concentrations of GFP (Ctrl-GFP) 
or FB1-GFP (+: 2 µg, ++: 5 µg) and then treated with 10 µM CCCP for 30 min. Cell 










Figure 22. Inhibition of the interaction between CHDH and SQSTM1 hampers 
mitochondrial degradation.  
(A, B) HeLa cells were transfected with PARK2 and either Ctrl-GFP or FB1-GFP. 
Following 24 h treatment with 10 µM CCCP, cells were subjected to 
immunocytochemical analysis using the indicated antibodies and then visualized 
under a confocal microscope. Scale bar = 10 µM. Statistical values for (A) are 
represented as bars with the mean ± S.D. * P < 0.05 (B) (n > 50). 
(C) HeLa cells were transfected with FB1-GFP and SQSTM1-MYC-HIS. After 
treatment with 10 µM CCCP for 24 h, cells were immunostained with MYC antibody 
and then observed under a confocal microscope. Scale bar = 10 µM. TUBA, tubulin, 
alpha. 
(D) Stable SN4741-Ctrl or SN4741-shCHDH cells were transfected with GFP-LC3 
and Mito-RFP and then treated with 100 µM MPP+ for 4 h. Cells were examined 
under a confocal microscope. The expression level of CHDH was determined using 
western blot analysis (upper) and the colocalization coefficient (%) between GFP-LC3 
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and Mito-RFP was determined (lower). Bars represent the mean ± S.D. * P < 0.0001 








Figure 23. Proposed role of CHDH in mitophagy.  
CHDH resides on both the OM and IM of mitochondria and exposes its FB1 domain-
containing N terminus to the cytosol on the OM. Following mitochondrial 
depolarization, CHDH accumulates on the OM probably through VDAC1 and 












Although CHDH has been proposed to localize to the IM of mitochondria,1, 32, 33 it 
is surprising to note that no report has clearly demonstrated the presence of CHDH in 
the IM of mitochondria. My results indicate that CHDH resides on both the OM and 
IM of mitochondria. More interestingly, CHDH accumulates on the OM during 
mitochondrial depolarization. Thus, it appears that CHDH plays a dual role in choline 
conversion and mitophagy in the IM and OM, respectively, of mitochondria. 
Concordant with this hypothesis, I found no correlation between the enzymatic 
activity and mitophagic function of CHDH, in that enzyme activity-dead mutant of 
CHDH were functional in mitophagy and the CHDH FB1 domain was crucial only for 
mitophagy. In addition, my observation that betaine, the enzymatic product of CHDH, 
cannot rescue the impaired mitophagy caused by CHDH deficiency further 
distinguishes CHDH’s mitophagic activity from its enzymatic activity.  
Given this newly discovered role in mitophagy, the location of CHDH within 
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mitochondria becomes more important. PINK1 also resides on both the OM and IM of 
mitochondria, and is likewise involved in mitophagy. Although PINK1 is normally 
degraded in the IM of mitochondria following cleavage by PARL proteases,19 it 
accumulates on the mitochondrial surface to recruit PARK2 during mitophagy.20, 42 In 
contrast to PINK1, however, western blot analysis did not show any cleavage or 
posttranslational modification, such as ubiquitination, of CHDH during mitophagy, 
suggesting that the accumulation of CHDH on the OM may not be accompanied by 
such modifications. Cardiolipin, a phospholipid located on the mitochondrial IM, is 
externalized to the OM by PLSCR3 following mitochondrial injury, where it interacts 
with LC3.35 However, I observed no significant effect of PLSCR3 on the 
accumulation of CHDH in the OM. Instead, I found that the accumulation of CHDH 
on the OM depends on the mitochondrial potential and may use the VDAC1-
containing mitochondrial membrane contact site as a path.  
It appears that the accumulation of CHDH on the OM of depolarized 
mitochondria is critical to facilitate interaction with cytosolic SQSTM1. In particular, 
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the CHDH N-terminal region, which is approximately 20 kDa in size and exposed to 
the cytosol in the FB1 domain, seems to be important for this interaction. Although the 
CHDH FB1 domain is required for this interaction and ectopic expression of the 
CHDH FB1 domain interrupts the interaction of CHDH with SQSTM1, it remains 
unclear whether the CHDH FB1 domain alone is sufficient to recruit SQSTM1 onto 
damaged mitochondria. By BLAST search, I found that there was no significant FB1 
domain-containing protein in human proteome. My observation that TOMM20-FB1-
GFP functioned in recruiting LC3 to depolarized mitochondria in the presence of 
CCCP does not exclude a mechanism in which other mitophagic component(s) or 
machinery, such as PARK2 substrates, operate in parallel during mitophagy, in 
addition to the presence of CHDH on the OM. 
    Although the ubiquitination of mitochondrial substrates by PARK2 is also crucial 
to recruit SQSTM1 into impaired mitochondria,26, 43, 44 it has previously been reported 
that SQSTM1 interacts with non-ubiquitinated substrates via its PB1 domain.38, 39 The 
PB1 domain is responsible for forming SQSTM1 aggregates through self- or hetero-
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oligomerization45, 46 and is required for mitochondrial aggregation and localization of 
SQSTM1 to mitochondria during CCCP conditions.44 Here, I elucidate the mechanism 
by which SQSTM1 may be recruited into impaired mitochondria, involving an 
interaction between SQSTM1 and non-ubiquitinated CHDH on the OM of 
mitochondria. Although I observed some interaction of SQSTM1 with CHDH at the 
steady-state level required for basal mitophagy, the interaction drastically increased 
upon mitophagy induction. Despite some debate on the necessity and sufficiency of 
SQSTM1 in mitochondrial clearance,11, 26, 44, 47 the results from my assays show that 
SQSTM1 is necessary for the degradation of depolarized mitochondria. It remains 
possible that SQSTM1 and other adaptor proteins may work together in mitophagy. 
While SQSTM1 is crucial in mediating mitophagy in several cell lines, it does not act 
alone, because knockdown of CHDH expression suppressed CCCP-induced LC3 
recruitment into the mitochondria by just over 50%, despite complete inhibition of the 
colocalization of SQSTM1 with mitochondria. Thus, in the absence of SQSTM1, 
other adaptors, such as HDAC6, may compensate for SQSTM1 deficiency.43, 48 
 
８４ 
The effect of CHDH on mitophagy was displayed largely with PINK1 and PARK2. In 
the absence of PINK1 and PARK2, however, CHDH overexpression could still 
stimulate mitophagy, while absolute levels of mitophagy were reduced. Similarly, 
PARK2-mediated mitophagy was significantly impaired in the absence of CHDH. The 
function of CHDH appears to be independent of PINK1 and PARK2, since neither the 
recruitment of PARK2 to depolarized mitochondria nor the stabilization of PINK1 
was affected by CHDH. Further, CHDH is apparently not a substrate of PARK2 and 
its interaction with SQSTM1 is PARK2-independent. My current hypothesis is that 
CHDH functions in parallel with PINK1/PARK2 pathway in mitophagy. Thus, 
CHDH is also important for the recruitment of LC3 into mitochondria in PARK2-
mediated mitophagy. In addition to PINK1 and PARK2, BNIP3L/NIX and FUNDC1 
have recently been reported to function in hypoxial mitophagy.49, 50  While it seems 
that CHDH may not function during hypoxial mitophagy (data not shown), I now add 
CHDH to the list of mitophagy coordinators. In conclusion, CHDH accumulates on 
the OM of mitochondria following mitochondrial damage and interacts there with 
 
８５ 
SQSTM1 to recruit LC3 into the impaired mitochondria for mitophagic clearance (Fig. 
23). This mitophagic function of CHDH is independent of its conventional enzymatic 
activity but is necessary for PARK2-mediated mitophagy. Finally, the implications of 
CHDH malfunction in mitophagy-associated pathology are now widely open and 
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새로운 Mitophagy 조질인자로서의 CHDH 기능 연구  
CHDH (choline dehydrogenase) 는 choline을 betaine aldehyde로 
전환시키는 효소이고 미토콘드리아에 존재한다. 본 연구에서는 이미 
알려져 있는 효소의 기능과는 별개로, mitophagy에서 CHDH의 역할을 
밝혔다. CHDH의 발현을 저해시키면 CCCP에 의해 유도되는 mitophagy가 
정상적으로 일어나지 않아 탈분극된 미토콘드리아의 제거가 
저해되었으며, CHDH를 과발현 시켰을 때에는 mitophagy가 좀 더 활발히 
일어났다. 이러한 현상은 이미 mitophagy에 중요하다고 잘 알려져 있는 
PARK2와 연계되어 일어났다. CHDH는 종래 보고와는 달리 
미토콘드리아의 내막과 외막에 동시에 존재했으며 mitophagy가 유도될 
때 외막의 CHDH가 좀 더 증가함을 관찰하였다. PARK2의 E3 ligase 
기능에 의한 기질들의 ubiquitination에 의해 mitophagy가 일어난다는 
기존 보고와 달리, CHDH는 PARK2의 기질이 아니었다. PARK2와 무관하게 
 
１０１ 
SQSTM1과 결합함으로써 mitophagy를 매개했고, CHDH의 FB1 도메인이 
SQSTM1과의 결합에 중요함을 밝혔다. 따라서, FB1 도메인만 세포질에 
과발현 시키면 SQSTM1과 경쟁적으로 결합함으로써 mitophagy를 
저해함을 관찰할 수 있었다. CHDH는 SQSTM1과 결합한 뒤, LC3와 3중 
구조를 형성함으로써 autophagosome을 미토콘드리아쪽으로 유도할 수 
있었으며, CCCP에 의한 mitophagy 뿐만 아니라, MPP+에 의해 유도되는 
mitophagy에도 CHDH가 기능하고 있었다. 결론적으로, CHDH는 
mitophagy의 cargo 인식단계에서 SQSTM1과 결합함으로써 PARK2에 
의한 mitophagy에 중요한 역할을 담당함을 알 수 있다.      
Part Ⅱ 
 






    Damaged mitochondria are targeted for degradation by an autophagy pathway 
known as mitophagy. Despite efforts to unravel the mechanisms underlying 
mitophagy, aspects of mitophagy regulation remain largely unknown. In this study, by 
using a cell-based fluorescence assay reflecting CCCP-induced mitophagy to screen a 
mitochondrial protein cDNA library, we identified PDK4 as a mitophagy regulator. 
PDK4 enhanced pyruvate levels in both cytosol and mitochondria, and the pyruvate 
was required to stabilize PINK1 during mitochondrial depolarization. Accordingly, 
mitochondrial degradation was not efficient in the absence of pyruvate. This pyruvate-
mediated mitophagy was not affected by OXPHOS or cellular ATP level, thus 
independent of energy metabolism. Rather, pyruvate was required for the interaction 
between PINK1 and TOMM20 under CCCP condition and thus for subsequent 
PARK2 translocation and LC3 recruitment onto depolarized mitochondria. My results 
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Depolarized or impaired mitochondria are cleared by autophagic machinery 
during a process known as mitophagy. Mitophagy is part of a mitochondrial quality 
control system that coordinates mitochondrial dynamics, biogenesis, fission, and 
fusion; mitophagy dysfunction is thus associated with human diseases.1 Two recessive 
Parkinson’s disease (PD) genes, PINK1/PARK6 and PARK2/parkin, are key 
regulators of mitophagy. Although cell type and condition-specific factors for 
mitophagy were not clearly determined yet, there has been a great advance to 
understand the machinery and underlying mechanisms involved in mitophagy during 
recent years.2-4 Under carbonyl cyanide m-chlorophenyl hydrazone (CCCP) condition, 
accumulation of PINK1 on the mitochondrial outer membrane (OM) and the 
subsequent translocation of PARK2 to damaged mitochondria induce mitophagy.5 
However, identification of regulatory molecules in this process remains to be 
elucidated. Newly found novel mitophagy regulators are basically involved in 
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autophagic machinery1 or reside on mitochondrial OM.6 Or, they could be lipid7 and 
metal.8 However, metabolic approaches to mitophagy were not noticeable. 
Pyruvate is produced by the glycolysis pathway and serves as an important 
intermediary metabolite for the maintenance of cellular homeostasis by acting as a 
“fuel” for mitochondrial respiration.9, 10 Although it has been long period of our 
knowledge for pyruvate, specific carrier for pyruvate across the mitochondrial 
membrane was recently identified, termed mitochondrial pyruvate carrier (MPC).11, 12 
The metabolic reaction of mitochondrial pyruvate is regulated by the pyruvate 
dehydrogenase complex (PDC), which catalyzes the oxidation of pyruvate to acetyl 
CoA in the mitochondrial matrix and is responsible for many age-associated 
diseases.13, 14 In addition to its well-known role in the bioenergetics of the 
mitochondrial citric acid cycle, the protective effect of pyruvate on ischemic damage 
has been extensively studied over the last two decades.15-18 Interestingly, pyruvate’s 
role in ischemic damage is attributed to its anti-oxidative function,19, 20 which also 
contributes to its role in cancer progression under hypoxic conditions21 and to its 
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ability to mitigate myocardial infarction.22, 23 PDC activity is governed by pyruvate 
dehydrogenase kinase (PDK) which is regulated by the cellular level of pyruvate, 
acetyl Co-A, NADH and ATP.24 There is four isoform, PDK1, 2, 3, and 4 which are 
expressed tissue-specifically and differently modulates PDC activity.25-28  
Among these isoforms, PDK4 is highly expressed in skeletal muscle, heart 
and liver29, 30 that require high level of oxidation. And PDK4 negatively regulates PDC 
activity in response to changing nutrient levels.29, 31, 32 In agreement with this function, 
loss of PDK4 in pdk4-/- mice lowers glucose level and ameliorates glucose tolerance in 
diet-induced obese mice.33 The expression level of PDK4 is affected by various 
factors24, including starvation.34 Regarding autophagy, PDK4 leads to AMPK 
activation and subsequent mTOR inhibition.35 Recently, a genome-wide siRNA 
screening study reported that knockdown of PDK4 expression affects CCCP-induced 
mitophagy.3 Although these reports implicate that PDK4 regulates 




To identify the novel modulator of mitophagy, I performed a functional screening by 
using a cDNA expression library encoding mitochondrial proteins. Interestingly, 
PDK4 was isolated as the most effective clone which enhanced CCCP-induced 
mitochondria degradation. PDK4 affected mitophagy through upregulation of 
pyruvate level and PINK1 stabilization. 
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2. MATERIALS AND METHODS 
 
2.1. Functional screening of mitophagy regulators  
    HEK293T cells grown on multi-well culture plates were co-transfected with 
Mito-GFP and cDNA expression vectors for 24 h and then treated with 100 µM 
CCCP for 2 h. The intensities of GFP signals were measured using the ENVISION 
Multilabel Plate Reader (Perkin Elmer). The cDNA clones showing more than 10% 
reduction in GFP intensity compared to that in the control were first selected. The 
positive clones were further analyzed for their effects on mitophagy by western 
blotting using mitochondrial marker proteins. 
 
2.2. Cell lines and culture 
    Cells were grown in DMEM (HyClone, SH30243.01) supplemented with 10% 
fetal bovine serum (FBS) (HyClone, SH30919.03) and 50 U/mL each of penicillin 
and streptomycin, and were incubated at 37°C in an atmosphere containing 5% CO2. 
 
１０７ 
For experiments testing the effects of pyruvate, pyruvate-negative DMEM (SH30022) 
containing the same concentrations of FBS, penicillin and streptomycin was used. For 
glutamine-induced mitophagy, Leibovitz L-15 Medium (HyClone, SH30525) was 
modified to contain 25 mM glucose with basal 2 mM glutamine (Glucose group) or 
no glucose with 4 mM glutamine (Glutamine group). 
 
2.3. Plasmids and transfection 
    PDK4-HA was produced by subcloning PDK4 into pcDNA3-HA (Invitrogen). 
PARK2-GFP, GFP-GABARAPL1, GFP-GABARAPL2, and GFP-BNIP3L were 
constructed by subcloning target sequences into pEGFP vector (Invitrogen). Flag-
PARK2 and mRFP-LC3 were subcloned into p3XFLAG-CMV (Sigma Aldrich) and 
pDsRed-Monomer (BD Bioscience) vectors, respectively. GFP-LC3 has been 
described previously36 and PINK1-GFP was kindly gifted by Dr. J. Chung (Seoul 
National University, Korea). DNA transfections were performed with PolyFect 




2.4. Immunofluorescence microscopy and determination of colocalization 
coefficient 
    Cells grown on a coverslip were fixed with 4% paraformaldehyde and 
permeabilized with 0.01% digitonin. After blocking with 10% fetal bovine serum, 
cells were incubated with primary antibodies at dilutions ranging from 1:100 to 1:250, 
and subsequently with an Alexa Fluor-conjugated secondary antibody (Molecular 
Probes). Samples were visualized with a confocal laser scanning microscope (Carl 
Zeiss, LSM700). ZEN software (Carl Zeiss) and the images were subjected to the 
analysis of the colocalization coefficient. 
 
2.5. Measurement of pyruvate and ATP 
Pyruvate and ATP levels were determined by using the Pyruvate 
Colorimetric/Fluorometric Assay Kit (BioVision, K609-100) and the ENLITEN ATP 




2.6. Immunoprecipitation, western blot, and antibodies 
    Immunoprecipitation and western blot assays were performed as described 
previously37. After samples were separated by SDS-PAGE and transferred onto 
nitrocellulose membrane (Pall Corporation, 66485), the membranes were blocked 
with 5% skim milk and incubated with the following antibodies: HA (Santa Cruz, sc-
805), ACTB (sc-47778), TOMM20 (sc-17764), CANX (sc-11397), GFP (sc-8334), 
TUBA (sc-23948), CHDH (sc-102442), LC3 (Novus Biologicals, NB100-2220), 
TIMM23 (BD Bioscience, 611222), SOD2 (Upstate, 06-984), COX4I1 (Abcam, 
ab14744-100), PINK1 (Novus Biologicals, BC100-494; Santa Cruz, sc-33796) and 
FLAG (Sigma Aldrich, F3165). The blots were detected using the enhanced 
chemiluminescence (ECL) method. 
 
2.7. Transmission electron microscopy 
    Cells were fixed with 3% paraformaldehyde and 0.5% glutaraldehyde in 
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phosphate-buffered saline (PBS) at 4°C for 2 h. After serial dehydration with 70%, 
95%, and 100% ethanol for 30 min twice, London Resin White (Polyscience, 17411-
500) was used for infiltration for 24 h. During that time, the resin was refreshed at 8-h 
intervals. Polymerization was performed overnight at 50°C. Sectioned specimens 
were placed on the Formvar-coated nickel grid (Polyscience, 300 meshes, 24928) and 
stained with 2% uranyl acetate and Reynold’s lead citrate for 7 min each. Samples 
were washed with distilled water and then visualized under a transmission electron 
microscope (JEOL, JEM1010) at 80 kV. 
 
2.8. Mitochondrial fractionation 
    Mitochondrial fractionation by differential centrifugation was performed as 
described previously37.  
 
 
2.9. Measurement of mitochondrial membrane potential by 
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Tetramethylrhodamine, ethyl ester (TMRE) 
    Cells were stained with 100 nM TMRE for 20 min, rinsed with PBS to remove 
excess dye, and then replaced in their original growth medium. The signal intensity of 
TMRE was captured by a fluorescence microscope and analyzed using the ImageJ 
program. 
 
2.10. Statistical analysis 
    Quantitative data are represented as mean ± standard deviation. Statistical 











3.1. Functional screening of mitochondrial proteins identified PDK4 as a 
mitophagy stimulator 
To discover the novel factor(s) that regulate mitophagy, I established a cell-
based assay and performed a gain-of-function screening by using 437 cDNAs 
encoding mitochondrial proteins, as described in Methods (Fig. 1A). HEK293T cells 
were co-transfected with an individual cDNA and Mito-GFP, a mito-tracker,37 and 
then exposed to a high dose of CCCP (100 mM) for a short time to induce acute 
depolarization and rapid degradation of the mitochondria. I isolated five putative 
positive clones, which reduced the fluorescence of Mito-GFP relative to the levels of 
fluorescence in control cells (Fig. 1B). Among them, PDK4 appeared to have the 
strongest effect on the fluorescence of Mito-GFP.  
To further characterize the effects of PDK4 overexpression on mitophagy, I 
examined LC3-II conversion in PDK4-expressing cells. Ectopic expression of PDK4 
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in HEK293T cells increased LC3-II conversion per se after treatment with 10 M 
CCCP, while no difference was observed in untreated cells (Fig. 1C). LC3-II 
conversion was further enhanced in the presence of the vacuolar-type H+-ATPase 
inhibitor bafilomycin A1. When I incubated HeLa cells with CCCP and performed 
immunocytochemical analysis of mitochondria by using the mitochondrial TOMM20 
antibody, PDK4 overexpression greatly accelerated PARK2-mediated mitochondrial 
clearance (Fig. 2A). Western blot analysis similarly indicated accelerated degradation 
of the mitochondrial proteins TIMM23 and TOMM20 owing to PDK4 overexpression, 
while endoplasmic reticulum-bound protein CANX/calnexin and the cytosolic protein 
TUBA/tubulin were unaffected (Fig. 2B, C). Together, these results suggest that 
PDK4 functions to regulate CCCP-induced mitophagy. 
 
3.2. Increased pyruvate levels owing to PDK4 overexpression enhance mitophagy 
Because PDK4 is one of the pyruvate dehydrogenase kinases known to 
inhibit PDC activity, I thought it unlikely that PDK4-regulated pyruvate levels would 
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affect mitophagy. I found that PDK4 overexpression increased pyruvate levels by 40% 
in both the mitochondrial and the cytosolic fractions of HEK293T cells (Fig. 3A), as 
previously reported.38 Because cDNA screening indicated that both PDK3 and PKD4 
could affect mitophagy in the transfected cells, (Fig. 1B), I more closely examined the 
effects of PDK family members on pyruvate levels. Among the members of the PDK 
family, overexpression of PDK4 had a significant effect on pyruvate levels in both 
mitochondrial and cytosolic fractions, while PDK3 had a modest, but insignificant 
effect (Fig. 3B). In contrast, PDK1 and PDK2 did not affect pyruvate levels. 
Interestingly, the cellular levels of pyruvate owing to PDK4 overexpression were 
similar to the levels resulting from pyruvate treatment of untransfected cells (Fig. 3B, 
+Pyr), and these levels did not increase further when PKD4-overexpressing cells were 
treated with pyruvate (Fig. 3B, PDK4+Pyr). These results indicated that PDK4 might 
function through pyruvate to regulate mitophagy in HEK293T cells. 
To test this hypothesis, I used western blotting to monitor mitophagy in the 
absence or presence of pyruvate (Fig. 3C). The mitochondrial proteins TOMM20, 
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TIMM23, SOD2, COX4I1, and CHDH, but not the cellular proteins CANX and 
TUBA, were degraded by CCCP treatment, and their degradation was augmented by 
pyruvate treatment. Similar results were observed with confocal image analysis 
showing that the clearance of Mito-RFP was enhanced from 15.2% to 38.2% by 
pyruvate treatment (Fig. 3D). Furthermore, electron microcopy revealed extensive 
digestion of mitochondria in the autophagic vesicles in the presence of pyruvate, while 
in the absence of pyruvate, the inner membrane (IM) structure of mitochondria and 
fragmented mitochondria still remained in the vesicles (Fig. 4A, B). Collectively, 
these results suggest that pyruvate stimulates mitophagy via a mechanism that is 
dependent on the ability of PDK4 to increase pyruvate levels. 
 
3.3. Pyruvate-mediated mitophagy is independent of energy metabolism 
  Since pyruvate is the major energy source for aerobic respiration and is 
related to cellular energetics, I considered the mechanism linking energy metabolism 
to mitophagy. I first wondered whether PDK4 overexpression and pyruvate treatment 
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might regulate ATP production. Measurement of ATP levels revealed that PDK4 
overexpression lowered ATP content in both the cytosol and the mitochondria, while 
pyruvate treatment increased it (Fig. 5A). Because PDK4 and pyruvate both stimulate 
mitophagy, these results suggest that neither PDK4-mediated nor pyruvate-mediated 
mitophagy is associated with ATP content. Recently, Melser et al reported that 
glutamine-induced oxidative phosphorylation activates mitophagy with a concomitant 
increase in ATP content.39 Thus, I examined the association of oxidative 
phosphorylation with PDK4-mediated mitophagy. As previously reported, cells grown 
on glutamine show more degradation of mitochondrial proteins than do cells grown on 
glucose (Fig. 5B); however, overexpression of PDK4 did not affect mitochondrial 
protein degradation. I used the TCA cycle intermediate citrate to assess the 
relationship between ATP and mitophagy further (Fig. 5C, D). Different ATP 
contents by PDK4 overexpression and citrate treatment (Fig. 5C) were applied to the 
mitophagy assay using western blot (Fig. 5D). Supplementary citrate did not affect 
mitophagy compared to that observed in citrate-lacking controls, and that PDK4 
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expression accelerated mitochondria clearance (Fig. 5D). These results indicate that 
PDK4–pyruvate axis functions independently of OXPHOS-ATP-mediated mitophagy. 
 
3.4. Pyruvate is required for PINK stabilization and enhances PARK2 and LC3 
recruitment onto depolarized mitochondria 
To examine the mechanism by which pyruvate stimulates mitophagy, I 
tested the hypothesis that pyruvate affects the interaction between mitochondrial 
BNIP3L/NIX and autophagosomal LC3. BNIP3L/NIX has previously been reported 
to mediate CCCP-induced mitophagy via its interaction with LC3.40, 41 Using confocal 
microscopy, I found that pyruvate did not significantly affect the co-localization of 
GFP-BNIP3L/NIX and mRFP-LC3 (Fig. 6). Since CCCP-induced mitophagy is 
mediated by the accumulation of PINK1 on the OM of mitochondria and the 
subsequent recruitment of PARK2, I examined the effects of pyruvate on this 
machinery in HeLa cells. Surprisingly, I observed that CCCP induced the 
accumulation of PINK1 in the presence, but not in the absence, of pyruvate (Fig. 7A), 
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indicating that pyruvate is required for the stabilization of PINK. This effect of 
pyruvate on PINK stabilization was also observed by confocal microscopy using 
Mito-RFP and PINK1-GFP (Fig. 7B). 
The current model of PINK1 processing states that PINK is cleaved by 
mitochondrial proteases such as PARL on the inner membrane (IM) of mitochondria 
and then degraded by proteasomes.42, 43 To address what happened to PINK1 in the 
absence of pyruvate under CCCP treatment, I performed western blot analysis after 
treatment with MG132, a proteasome inhibitor (Fig. 7C). The result showed that in 
CCCP-treated cells, in the absence of pyruvate, PINK1 was cleaved and degraded 
rather than being accumulated on the mitochondrial OM. The cleavage and 
degradation were inhibited by MG132, resulting in the accumulation of the 52-kDa 
PINK1 fragment in the mitochondria. In contrast, in the presence of pyruvate, PINK1 
was accumulated on the mitochondrial OM, as indicated by the detection of the full-
length 64-kDa protein. This result further supports the necessity of pyruvate for 
PINK1 stabilization. Since PINK1 binds to TOMM complex during stabilization on 
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the mitochondrial OM under CCCP condition,44 I addressed whether pyruvate was 
required for their interaction. An immuoprecipitaion analysis with endogenous 
TOMM20 was performed and resulted in interaction with PINK1 only in the presence 
of pyruvate (Fig. 7D). I found that this requirement for pyruvate was highly specific as 
the three pyruvate analogs bromopyruvate, phenylpyruvate, and α-ketobutyrate45 were 
unable to stabilize PINK1 (Fig. 7E). Additionally, I found that pyruvate did not 
significantly affect mitochondrial membrane potential (MMP, Fig. 7F). 
Next, I examined the translocation of PARK2 to depolarized mitochondria 
following PINK1 stabilization. Using mitochondria from HeLa cells overexpressing 
FLAG-PARK2, I found that CCCP-induced PARK2 recruitment onto the 
mitochondria increased by 4.6 fold when cells were treated with pyruvate (Fig. 8A). 
Furthermore, GFP-LC3 recruitment onto the mitochondria was also significantly 
increased by pyruvate, as determined by the co-localization coefficient calculated 
using confocal microscopy (Fig. 8B), suggesting that pyruvate is required for the 
conventional PINK1/PARK2 pathway of mitophagy. I further tested the effects of 
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pyruvate on the co-localization of LC3 and gamma-aminobutyric acid receptor-
associated protein (GABARAP) to the mitochondria since the GABARAP was 
previously reported to play a role in mitophagy like LC3.30 However, pyruvate did not 
affect the co-localization of LC3 and GABARAP (Fig. 8C). Moreover, I found that 
pyruvate did not affect the mitophagy mediated by choline dehydrogenase (CHDH), 
an important molecule for mitophagy.27 (Fig. 8D) 
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Figure 1. Isolation of PDK4 as a mitophagy enhancer by functional screening  
(A) Schematic diagram depicting the functional screening. A detailed description of 
the screening is provided in the Methods section.  
(B) Genes showing high impact on the fluorescence of Mito-GFP are represented. 
(C) Western blot analysis of cell lysates prepared from mock (DMSO)-treated or 
CCCP-treated HEK293T cells overexpressing PDK4-HA, either in the presence or in 











Figure 2. Overexpression of PDK4 enhances mitophagy  
(A) HeLa cells were transfected with PARK2-GFP and either control vector (Ctrl) or 
PDK4. After treatment with 20 µM CCCP for 6 h, cells were fixed and 
immunostained with TOMM20 antibody. TOMM20-negative and PARK2-GFP-
positive cells (n > 100) were counted and depicted. * P < 0.001. 
(B, C) HeLa cells were transfected with PARK2-GFP and PDK4-HA, and then 
treated with 10 µM CCCP for 30 h. Cell lysates were analyzed with western blotting 
(B) and the signals on the blot were quantified (C). The α-tubulin (TUBA) served as a 







Figure 3. Enhanced pyruvate levels owing to PDK4 overexpression  
(A) HEK293T cells were transfected with either control vector (Ctrl) or PDK4 and 
then treated with 1 mM pyruvate for 4.5 h. Pure mitochondrial and cytosolic fractions 
were obtained and pyruvate levels were measured, as described in Methods. * P < 
0.05. 
(B) HEK293T cells were transfected with PDK family members and were then left 
untreated or incubated with 1 mM pyruvate for 4.5 h. After cell lysates were 
fractionated into the mitochondria and the cytosol fractions, pyruvate levels in the 
fractions were determined as described in Methods. * P < 0.01, ** P < 0.05. 
(C) HepG2 cells were either left untreated or treated with 1 mM pyruvate for 2 h and 
then exposed to 10 µM CCCP for 24 h. Cell lysates were subjected to western blot 
analysis.  
(D) HeLa-Mito-RFP stable cells were transfected with PARK2-GFP and incubated 
with 1 mM pyruvate for 30 min prior to the treatment with 10 µM CCCP for 24 h. 
Lack of RFP signal under a fluorescence microscope is indicative of cleared 
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Figure 4. PDK4 increases mitochondrial pyruvate levels, thereby enhancing 
mitophagy  
(A, B) HepG2 cells were treated with 1 mM pyruvate for 30 min and subsequently 
treated with 10 µM CCCP for 2 h. Cells were observed under a transmission electron 
microscope. Scale bar = 1 µm (upper panel) and 200 nm (zoom-in lower panel) (A). 








Figure 5. Pyruvate-mediated mitophagy is not correlated with energy 
metabolism  
(A) HEK293T cells were either transfected with PDK4 for 24 h or incubated with 1 
mM pyruvate for 4.5 h. Cell extracts were prepared and separated into the cytosol and 
mitochondria fractions, followed by ATP assay, as described in Methods. ATP 
contents relative to that in the control (Ctrl) are represented.  
(B) HeLa cells grown in either 25 mM glucose or 4 mM glutamine-containing media 
were transfected with PDK4-HA. After treatment with 20 µg/mL cycloheximide 
(CHX) for 8 h, cell extracts were prepared and analyzed by western blotting (upper). 
The signals on the blots were quantified (lower). 
(C) HEK293T cells were transfected with PDK4 and then left untreated or treated 
with 1 mM citrate for 2 h. ATP content was measured as described in (A). * P < 0.001, 
** P < 0.005.  
(D) HEK293T cells were transfected with PDK4 and then treated with 10 µM CCCP 











Figure 6. Effect of pyruvate on BNIP3L-mediated LC3 recruitment  
HepG2 cells were cotransfected with GFP-BNIP3L and mRFP-LC3 were first treated 
with 1 mM pyruvate for 2 h and then with 10 µM CCCP for 30 min. Samples were 
analyzed by confocal microscopy. Scale bar = 10 µm (upper). Colocalization 








Figure 7. Pyruvate induces PINK1 stabilization  
(A) HeLa cells were either left untreated or were incubated with 1 mM pyruvate for 2 
h, followed by treatment with 10 µM CCCP for 2 h. Cell extracts were analyzed by 
western blotting.  
(B) PINK1-GFP and Mito-RFP were transfected into HeLa cells, and the cells were 
subjected to treatment with 1 mM pyruvate for 2 h before treatment with 10 µM 
CCCP for 3 h. Samples were fixed and analyzed by confocal microscopy. Scale bar = 
10 µm. 
(C) HeLa cells were incubated with 1 mM pyruvate or 10 µM MG132 for 2 h and 
then exposed to 10 µM CCCP for 3 h. Mitochondria were then purified and analyzed 
by western blotting. 
(D) HeLa cells were pretreated with 1 mM pyruvate for 1 h and then treated with 10 
µM CCCP for 3 h. Pure mitochondria were obtained and subjected to 
immunoprecipitation with TOMM20 antibody. 
(E) HeLa cells were first treated with 1 mM pyruvate or the pyruvate analogs 
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bromopyruvate (BR), phenylpyruvate (PH), and α-ketobutyrate (KE) for 2 h, and then 
with 10 µM CCCP for 2 h. The cells were then subjected to western blotting. 
(F) HeLa cells were treated with 1 mM pyruvate for 2 h prior to the treatment with 10 
µM CCCP for 1 h. Cells were stained with TMRE solution and analyzed as described 









Figure 8. Pyruvate enhances PARK2 translocation and LC3 recruitment onto 
depolarized mitochondria  
(A) HeLa cells were transfected with FLAG-PARK2 and incubated with 1 mM 
pyruvate for 2 h before the treatment with 10 µM CCCP for 2 h. Then, the 
mitochondrial fraction was prepared and analyzed by western blotting. The signal of 
mitochondrial FLAG-PARK2 on the blot was quantified and represented as a fold 
change relative to that of whole cell lysate (WCL).  
(B) After being transfected with FLAG-PARK2, Mito-RFP, and GFP-LC3, HeLa 
cells were treated with 1 mM pyruvate for 2 h prior to the treatment with 10 µM 
CCCP for 4 h. Cells were fixed and observed under a confocal microscope (right). 
Colocalization coefficient was determined from the fluorescence images (left). Scale 
bar = 10 µm. * P < 0.005 (n > 50). 
(C) HeLa cells were cotransfected with Mito-RFP and GFP-LC3, GFP-GABARAPL1, 
or GFP-GABARAPL2. After incubation with 1 mM pyruvate for 30 min, cells were 
treated with 10 µM CCCP for 4 h and then analyzed by confocal microscopy. 
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Colocalization coefficients were measured as described in Methods. * P < 0.001 (n > 
50). 
(D) HeLa and HeLa-shCHDH knockdown cells were transfected with FLAG-PARK2 
and then treated with 1 mM pyruvate for 2 h before exposure to 10 µM CCCP for 24 h. 
After immunostaining with TOMM20 antibody, the numbers of TOMM 20-negative 









Figure 9. Proposed model for mitophagy.  
Mitochondrial depolarization induces PINK1 stabilization on the OM which requires 
pyruvate. Once PINK1 is stabilized, PARK2-mediated ubiquitination of substrates and 
PARK2-independent interaction between CHDH and SQSTM1 recruits LC3-











    In this study, PDK4 is regarded as a potential regulator that affects autophagy or 
mitophagy. PDK4 is known to be upregulated under fasting condition34 and leads to 
AMPK activation and mTOR inhibition35. In addition, a genome-wide siRNA 
screening study shows a possibility that PDK4 knockdown affects mitophagy in 
response to CCCP treatment3. Thus, PDK4 is supposed to regulate 
autophagy/mitophagy. However, there has been a remaining last piece of puzzle to 
elucidate the role of PDK4 in autophagy/mitophagy. Here, we provide a piece of 
evidence linking PDK4 to mitophagy rather than macroautophagy. LC3 conversion 
triggered by PDK4 was only observed in the presence of CCCP. In addition, 
subsequent mitophagic events, including elucidation for the role of PDK4 as a 
stabilizer of PINK1, collectively suggest that PDK4 functions in the mitochondria-
targeted process. Further, the strongest effect of PDK4 among PDK isoforms on the 
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increase of pyruvate level adds more evidence that PDK4 plays a role mainly in 
mitophagy. 
    As the mechanism of PDK4 function in mitophagy, we propose that pyruvate 
accumulation by PDK4 is essential for mitophagy. Especially, pyruvate is required for 
the stabilization of PINK1 on the OM of depolarized mitochondrion. Surprisingly, in 
the absence of pyruvate, the normal mitochondrial events occur even though cells 
were exposed to CCCP; PINK1 was imported into the IM of mitochondrion and 
degraded over there by proteasome.42-44 In addition to a recent report that TOMM 
complexes are required for PINK1 stabilization by reciprocal interaction,44 we 
suggests pyruvate as an enhancer for the interaction. Accordingly, pyruvate-mediated 
mitophagy belongs to canonical PINK1/PARK2 pathway by affecting PARK2 
translocation onto depolarized mitochondria and subsequent recruitment of LC3. 
Unlike the protective effect of pyruvate on ischemic damage, pyruvate analogues did 
not rescue the mitophagy, indicating that the role of pyruvate in mitophagy was not 
attributable to anti-oxidation activity of pyruvate.  
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However, the effects of pyruvate on the mitophagy seemed to occur in a cell-type 
specific manner. Our results showed that PINK1 was stabilization by pyruvate in 
HeLa and HepG2, while it was not in HEK293T cells. In HEK293T cells, 
overexpression of PDK4 and pyruvate treatment still stimulated mitophagy, while 
pyruvate treatment did not affect PINK1 stabilization. Thus, pyruvate may not be the 
only factor regulating the stability of PINK1 and accompanying mitophagy and other 
mechanism may play a role in the PDK4-mediated mitophagy. A hypotheses might be 
possible for this phenomenon. Pyruvate-free DMEM, the culture medium we used, 
has high level of glucose that is actively metabolized via glycolysis pathway to 
produce pyruvate. While cells were incubated with pyruvate-free DMEM before the 
experiments, there might already be sufficient amount of pyruvate produced from the 
glycolysis pathway by the cell-type specific manner. Or, metabolic status or 
mitochondrial activity in addition to pyruvate may also contribute to the PDK4-
mediated mitophagy. Identification of this pathway remains to be further addressed. 
Nonetheless, pyruvate was essential in the mitophagy in most of cells we examined.  
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Evaluation of pyruvate level should be considered to measure mitophagy in cell 
level or in vivo. Physiological concentration of pyruvate is approximately 0.1 to 0.2 
mM9 and the effective concentration of pyruvate in mitophagy we utilized in our assay 
was 1 mM. Given that pyruvate normally transverses blood brain barrier,46 
administration of pyruvate might be a candidate for mitochondrial defect-associated 
neurodegenerative disease, if proper half-life was determined. Our preliminary data 
indicate that pyruvate is involved in 1-methyl-4-phenylpyridinium (MPP+)-induced 
mitochondrial damage and cell death. Although the precise mechanism was remained 
to be elucidated, we propose PDK4 as major modulator of pyruvate that stabilizes 
PINK1 on the depolarized mitochondrion and thus activates mitophagy. Collectively 
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피루브산이 Mitophagy 과정에서 PINK1 안정화에 미치는 영향  
손상된 미토콘드리아는 autophagy 기작에 의해 제거되는데, 이를 
mitophagy라 한다. Mitophagy의 분자적 조절 기작을 밝히려는 많은 
노력에도 불구하고, 아직도 많은 부분이 미해결 과제로 남아있다. 본 
연구에서는, 세포를 기반으로 한 형광 검출 방법과 미토콘드리아 cDNA 
library를 사용하여 CCCP에 의해 유도되는 mitophagy를 조절하는 
유전자를 스크리닝 하였고, PDK4를 동정하였다. PDK4는 세포질과 
미토콘드리아에서 피루브산의 양을 증가시켰고, 이는 탈분극된 
미토콘드리아에서 PINK1 단백질의 안정화에 필요함을 관찰하였다. 
피루브산이 결핍된 조건에서는 미토콘드리아의 제거가 잘 일어나지 
않았다. 피루브산을 매개해서 일어나는 mitophagy는 산화적 인산화나 
세포내 ATP 양과는 무관하였고, 따라서 세포내 에너지 대사와는 
무관함을 의미한다. 대신에 CCCP 조건에서 PINK1이 TOMM 중합체와 
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결합하는데 중요한 역할을 함으로써 PINK1의 안정화에 영향을 주고 
있음을 밝혔다. 또한, 피루브산은 mitophagy의 다음 기작인 PARK2와 
LC3가 미토콘드리아로 이동하는데도 영향을 주고 있었다. 따라서, 본 
연구는 피루브산이 CCCP에 의해 유도되는, PINK1/PARK2에 의한 
mitophagy에 중요한 역할을 함을 규명하였다.  
 
